Moderna posts bigger loss than expected as vaccine maker scales down manufacturing
Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down ...
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...
Moderna beats on revenue but loses more than expected as it scales down manufacturing
It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...
Yahoo Finance4d
Moderna norovirus vaccine trial on hold by US FDA over neurological side effect
Moderna has been banking on revenue from newer mRNA shots to make up for waning post-pandemic ... Most of those sales were generated by the COVID shot, which brought $923 million, compared to ...
Investing4d
Moderna posts bigger loss than expected as vaccine maker scales down manufacturing
The vaccine maker ... of its COVID-19 vaccine crashed from their peak during the pandemic and its respiratory syncytial virus (RSV) shot got less uptake than expected. Shares of Moderna, along ...
Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker.
Vaccine maker Moderna had no Valentine’s Day chocolates for investors when its financial results came out Friday. The company ...